Oncology Imaging

Medical imaging has become integral to cancer care, assessing the stage and location of cancerous tumors. By utilizing powerful imaging modalities including CT, MRI, MRA and PET/CT, oncology imaging radiologists are able to assist referring physicians in the detection and diagnosis of cancer.

Paired CT offers instant results of liver tumor treatment

Two successive pairs of specialized CT scans can, within one minute, show whether targeted chemotherapy is working to kill liver tumors, according to a study published in the January issue of Radiology.

U.S. fails to meet most cancer screening goals

Although the general U.S. population did not meet most Healthy People 2010 goals for cancer screening, cancer survivors met all goals except cervical cancer screening, according to a study published Dec. 27, 2012, in Frontiers in Cancer Epidemiology.

Certificate of need programs don’t slow IMRT use, prostate cancer costs

Certificate of need programs do not limit the use of intensity modulated radiation therapy (IMRT) or control overall prostate cancer healthcare costs, according to a study published in the January issue of Journal of Urology.

Theragenics, Oncura ink brachytherapy deal

Theragenics, a medical device company serving the surgical products and prostate cancer treatment markets, has signed a loading services agreement with Oncura, a unit of GE Healthcare, to provide worldwide brachytherapy loading services to Oncura.

Radiation therapy vacancy rates dip

Vacancy rates for radiation therapists declined in 2012, according to the American Society of Radiologic Technologists (ASRT) Staffing & Workplace Survey 2012.

Given Imaging seeks FDA approval for GI tract capsule

Given Imaging has filed an FDA application seeking regulatory clearance to market its PillCam Colon 2 capsule for visualization of the lower gastrointestinal (GI) tract.

RSNA: Lung cancer screening—where hope and fear converge

CHICAGO—My biggest hope was that the National Lung Screening Trial (NLST) would work, Reginald Munden, MD, MBA, of MD Anderson Cancer Center in Houston, told an audience Nov. 26 at the annual meeting of the Radiological Society of North America (RSNA). Munden also shared his biggest fear—that  NLST would work.

RSNA: Dr. No-name not welcome in lung cancer screening model

CHICAGO—Several decades ago, it wasn’t uncommon for fledgling radiologists, pathologists and anesthesiologists to be advised that they could tell if they were doing a good job if patients did not know their name. The no-name practice model no longer suffices and is a disservice to radiologists and their patients, according to panelists during the RSNA opening session on Nov. 25.

Around the web

CCTA is being utilized more and more for the diagnosis and management of suspected coronary artery disease. An international group of specialists shared their perspective on this ongoing trend.

The new technology shows early potential to make a significant impact on imaging workflows and patient care. 

Richard Heller III, MD, RSNA board member and senior VP of policy at Radiology Partners, offers an overview of policies in Congress that are directly impacting imaging.